US Bancorp
RVMD icon

US Bancorp’s Revolution Medicines RVMD Stock Holding History

US Bancorp’s Portfolio RVMD Stock Details RVMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$626K Sell
3,344
-484
-13% -$70.7K ﹤0.01% 1439
2026
Q1 		$372K Sell
3,828
-33
-0.9% -$3.33K ﹤0.01% 1659
2025
Q4 		$308K Buy
3,861
+693
+22% +$45.4K ﹤0.01% 1803
2025
Q3 		$148K Buy
3,168
+1,996
+170% +$78.2K ﹤0.01% 2159
2025
Q2 		$43.1K Sell
1,172
-69
-6% -$2.65K ﹤0.01% 2842
2025
Q1 		$43.9K Buy
1,241
+50
+4% +$2.03K ﹤0.01% 2815
2024
Q4 		$52.1K Sell
1,191
-1,264
-51% -$63.8K ﹤0.01% 2722
2024
Q3 		$111K Sell
2,455
-496
-17% -$21.6K ﹤0.01% 2342
2024
Q2 		$115K Buy
2,951
+170
+6% +$6.35K ﹤0.01% 2267
2024
Q1 		$89.6K Buy
2,781
+522
+23% +$15.5K ﹤0.01% 2421
2023
Q4 		$64.8K Buy
2,259
+874
+63% +$21K ﹤0.01% 2534
2023
Q3 		$38.3K Sell
1,385
-190
-12% -$5.63K ﹤0.01% 2571
2023
Q2 		$42.1K Buy
1,575
+638
+68% +$15.7K ﹤0.01% 2593
2023
Q1 		$20.3K Buy
937
+572
+157% +$14.1K ﹤0.01% 2988
2022
Q4 		$8.69K Sell
365
-306
-46% -$6.51K ﹤0.01% 3341
2022
Q3 		$13K Buy
671
+200
+42% +$4.39K ﹤0.01% 3282
2022
Q2 		$9K Sell
471
-484
-51% -$9.42K ﹤0.01% 3400
2022
Q1 		$25K Buy
955
+355
+59% +$7.73K ﹤0.01% 2959
2021
Q4 		$15K Buy
600
+106
+21% +$2.99K ﹤0.01% 3273
2021
Q3 		$13K Buy
494
+71
+17% +$2.07K ﹤0.01% 3335
2021
Q2 		$14K Buy
423
+359
+561% +$12.5K ﹤0.01% 3300
2021
Q1 		$3K Buy
+64
New +$2.87K ﹤0.01% 3636
2020
Q4 		– Sell
-600
Closed -$21K – 3869
2020
Q3 		$21K Buy
+600
New +$16.6K ﹤0.01% 2802

Other funds holding RVMD

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $21.7B AUM 79.24% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BBA
Baker Bros. Advisors New York $20B AUM 154.41% 1-Year Est. Return
DGM
Darwin Global Management St. Helier, Jersey $3.76B AUM 342.13% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
PBA
Paradigm Biocapital Advisors New York $5.34B AUM 380.18% 1-Year Est. Return

US Bancorp's RVMD Position: Q2 2026 in Review

US Bancorp reduced its Revolution Medicines (RVMD) stake by 13% in Q2 2026, selling an estimated $70.7K and leaving 3,344 shares worth $626K. The position accounts for ﹤0.01% of the portfolio, ranked #1439.

US Bancorp first reported a position in RVMD in Q3 2020 and has held it in 23 quarters since. 690 funds tracked by Wall St. Rank hold RVMD as of Q2 2026.

  • US Bancorp held 3,344 shares of Revolution Medicines worth $626K as of Q2 2026.
  • US Bancorp sold 484 Revolution Medicines shares in Q2 2026, an estimated $70.7K.
  • Revolution Medicines made up ﹤0.01% of US Bancorp's portfolio in Q2 2026, its #1439 holding.
  • US Bancorp first reported a position in Revolution Medicines in Q3 2020 and has held it in 23 quarters since.
  • 690 funds tracked by Wall St. Rank held Revolution Medicines as of Q2 2026.

Based on US Bancorp's 13F filing for Q2 2026, filed 12 Aug 2026.